


Insider Trading - Lyu Zhengguang - Form 4 SEC Filings












Home |
Archives |
Products |
About |
Contact |
FAQ |



New User?
Sign Up | 
Sign In









Form 4 Filings


Insider Buys


Significant Buys


Penny StocksInsider Buying


Insider Sales




Insider Buy Sell Ratios


Stock Options


Insider TradingStock Screener


Insider TradingGraph View


Insider Watch





Sec Filings Insider Trading - Lyu Zhengguang





Select Time period: 
1 Month
2 Months
3 Months
6 Months
1 Year
2 Years
3 Years
4 Years
All Data
 

     



google

   



yahoo!



Send this page to:  

Blog
  



Digg

  



Reddit

  



Facebook

  



Stumble

  



del.icio.us








Enter Stock Ticker Symbol or Cik:




Cik Lookup...






Search By Company or Insider Name:







"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch ==>>

What is insider trading>>



Email a friend >>...







Historical filings delayed by 6 months. New user?
Sign Up for real time data.
Existing user?
Sign In

Common stock purchase or sale:



TransactionDate
ReportedDate
Company
Symbol
InsiderRelationship
SharesTraded
AveragePrice
TotalAmount
SharesOwned
Filing




2016-11-30Purchase
2016-12-091:39 pm
Myos Rens Technology Inc
MYOS
Lyu ZhengguangDirector
34,337
$1.452
$49,853
117,842(Direct)
View


2016-09-23Purchase
2016-09-263:51 pm
Myos Rens Technology Inc
MYOS
Lyu ZhengguangDirector
50,000
$1.7
$84,995
83,505(Direct)
View


2016-09-01Purchase
2016-09-0712:11 pm
Myos Rens Technology Inc
MYOS
Lyu ZhengguangDirector
23,505
$1.598
$37,562
33,505(Direct)
View


2016-06-17Purchase
2016-06-2111:08 am
Myos Rens Technology Inc
MYOS
Lyu ZhengguangDirector
10,000
$1.65
$16,500
10,000(Direct)
View




Stock options: Exercise, Award, Grant, Conversion



TransactionDate
ReportedDate
ExercisableExpiration
Company
Symnbol
InsiderRelationship
SharesTraded
ConversionPrice
SharesOwned
Filing




2016-12-28Option Award
2016-12-304:32 pm
N/AN/A
Myos Rens Technology Inc
MYOS
Lyu ZhengguangDirector
4,386
$0
122,228(Direct)
View









    © 2005-2017 SecForm4.Com All rights reserved.
    Archives:
    2017 2016 2015 2014 2013 2012 ... 
    Tue, 25 Jul 2017 14:17:31 -0500
  

    SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
    SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC).
Terms of Use |
    Privacy Statement |
  




















































Lyu Zhengguang - SEC Form 4 Insider Trading Screener - OpenInsider











OpenInsider

Latest

Latest Cluster Buys
Latest Insider Trading (all filings)
Latest Insider Purchases
Latest Insider Purchases $25k+
Latest Officer Purchases $25k+
Latest CEO/CFO Purchases $25k+
Latest Insider Sales
Latest Insider Sales $100k+
Latest Officer Sales $100k+
Latest CEO/CFO Sales $100k+


Top

Top Officer Purchases Today
Top Officer Purchases Past Week
Top Officer Purchases Past Month
Top Insider Purchases Today
Top Insider Purchases Past Week
Top Insider Purchases Past Month
Top Insider Sales Today
Top Insider Sales Past Week
Top Insider Sales Past Month


By Symbol

Officer Purchases $25k+ Today
Officer Purchases $25k+ Past Week
Officer Purchases $25k+ Past Month
Officer Sales $100k+ Today
Officer Sales $200k+ Past Week
Officer Sales $500k+ Past Month
Officer Sales $100k+ Today (no opt-ex)
Officer Sales $200k+ Past Week (no opt-ex)
Officer Sales $500k+ Past Month (no opt-ex)
Insider Purchases of Penny Stocks, Past Month
Insider Sales of Penny Stocks, Past Month


Charts

Contact











Lyu Zhengguang - SEC Form 4 Insider Trading ScreenerCIK: 1667846 - Address: 16Th Floor, Building A, Fenghuo Plaza, No.88 Yun Long Shan Road, Nanjing, F4 210019 




General

Tickers
Insider
Sh Price $



Lqdty M$






Date

Filing Date

All dates
Custom
Latest day
Last 3 days
Last 1 week
Last 2 weeks
Last 1 month
Last 2 months
Last 3 months
Last 6 months
Last 1 year
Last 2 years
Last 4 years



  



Trade Date

All dates
Custom
Latest day
Last 3 days
Last 1 week
Last 2 weeks
Last 1 month
Last 2 months
Last 3 months
Last 6 months
Last 1 year
Last 2 years
Last 4 years



  


Filing Delay



N Days Ago








Transaction Filing

 P - Purchase S - Sale A - Grant D - Sale to Iss G - Gift F - Tax M - Option Ex X - Option Ex C - Cnv Deriv W - Inherited

 No deriv


 Multiple Days

Traded K$



Own Chg %








Industry




All Sectors (except Funds)
Agriculture, Forestry, Fish
Mining
Construction
Manufacturing
Transportation & Utilities
Wholesale Trade
Retail Trade
Financial
Services
Closed-End Funds


























Insider Title

  Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other






Group by


Filing
Company





Company Totals

Num Filings



Num Insiders



Num Officers



Traded K$



Own Chg %







Sort by

Filing Date
Trade Date
Ticker Symbol
Trade Value


Max Results
Page


clear


Real-time CSV, Options, Alerts








4 results -  -  -  -  -  -  - TCcnt1d1w1m6mP4+3-1-10+50 


X
Filing Date
Trade Date
Ticker
Insider NameInsider Title
Trade Type 
Share Price
Shares Traded
Shares Owned
Own chg
Value Traded
1d ret
1w ret
1m ret
6m ret



M2016-12-09 13:39:302016-11-30 MYOSLyu ZhengguangDirP - Purchase$1.45+34,337117,842+41%+$49,8530+7-10
2016-09-26 15:51:042016-09-23 MYOSLyu ZhengguangDirP - Purchase$1.70+50,00083,505+149%+$84,995-4-4-8+76
M2016-09-07 12:11:572016-09-01 MYOSLyu ZhengguangDirP - Purchase$1.60+23,50533,505+235%+$37,562+3+1-3+106
2016-06-21 11:08:122016-06-17 MYOSLyu ZhengguangDirP - Purchase$1.65+10,00010,000New+$16,500+14-8-18-32
Real-time CSV? Options? Alerts? Contact us!



AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price


S - SaleSale of securities on an exchange or to another personS - Sale+OESale of securities on an exchange or to another person (after option exercise)F - TaxPayment of exercise price or tax liability using portion of securities received from the companyP - PurchasePurchase of securities on an exchange or from another person 

Return to top
Copyright © 2017 openinsider.com. All rights reserved.















LYU ZHENGGUANG Top Holdings  

































WhaleWisdom









Search All
Search 13F Filers Only
Search SEC Filer
Search Stocks Only
Search Mgmt Inv. Cos Only
ETFs Only
Search Active




















                      LYU ZHENGGUANG
                    

•   NANJING, F4
                      
How do I update this listing?




                                             LYU Zhengguang is based out of Nanjing.   
                                           














Summary
13D/G
Insider (Form 4)



   Create Email Alert
 




×
Email Notification.







                   ***Log In or
                   Sign-up
                   to see more advanced email alert options such as selecting any type of
                   SEC form, multiple filers or classes of filers, and much more.***
                 

                    ...or to simply have an email sent to you whenever we receive a new
                           13F filing from LYU ZHENGGUANG, enter your
                    email address below and choose 'Submit'.
                

Your email:








Cancel














Contact Info




lyu zhengguang


16TH FLOOR, BUILDING A, FENGHUO PLAZA

NANJING
F4
                                                        
                                                    210019









Recent SEC Filings




4 filed on 12/30/2016
4 filed on 12/09/2016
4 filed on 09/26/2016
4 filed on 09/07/2016
3 filed on 03/14/2016
















Schedule 13D and 13G events since 03/31/2017

Subscription required



 
Form 4 - Non-derivative Insider Transactions Since 03/31/2017
Loading...








Elevate your investments
Try it for free



















ZHENGGUANG  LYU - CEO, founder, businessman - profile

















directorpedia.net - List of CEOs, founders, board members and company directors











ZHENGGUANG  LYU
Check out list of companies and businesses related to ZHENGGUANG  LYU. Find out ZHENGGUANG  LYU address and contact details. View other people related to ZHENGGUANG  LYU - coworkers, colleagues, companions, etc.
Address:   

C/O MYOS CORPORATION 45 HORSEHILL ROAD, SUITE 106 CEDAR KNOLLS 07927 NJ




Companies related to ZHENGGUANG  LYU
CIKCompany NamePositionCompany Address0001402479MYOS RENS TECHNOLOGY INC.Director 45 HORSEHILL ROAD SUITE 106 CEDAR KNOLLS 07927




ZHENGGUANG  LYU on the Web
Persons related to ZHENGGUANG  LYU - MYOS RENS TECHNOLOGY INC.NamePositionCityBuzz  AldrinDirector CEDAR KNOLLSLouis J.  AronneDirector MARINA DEL REYLouis J.  AronneDirector CEDAR KNOLLSRobert C. Jr.  AshtonChief Medical Officer CEDAR KNOLLSJeffrey L.  BernsteinCEO and President SAN MATEOAldrin  BuzzCedar KnollsDeFreitas  CarlCedar KnollsColker, MD, FACN  CarlonSan MateoColker, MD, FACN  CarlonMarina del ReyCarlon M  ColkerGREENWICHCarl  DeFreitasChief Financial Officer CEDAR KNOLLSCarl  DeFreitasChief Financial Officer CEDAR KNOLLSPeter  DiamandisDirector MARINA DEL REYPeter  DiamandisDirector CEDAR KNOLLSJanine  DiVenutoBALMVILLEJanine  DiVenuto10% Owner BALMVILLEJoseph  DosSantosInterim President and CFO CEDAR KNOLLSAndrew J.  EinhornCEDAR KNOLLSGlen R.  Fleischer CEDAR KNOLLSMathers  GeorgetteSan MateoRobert J  HaririDirector BERNARDSVILLERobert J  HaririBERNARDSVILLERobert J  HaririDirector MARINA DEL REYRobert J  HaririDirector CEDAR KNOLLSBernstein  J.B.San MateoBernstein  J.B.Marina del ReyJACK  LEVINENORTH MIAMI BEACHPeter  LevyCOO; Executive VP MARINA DEL REYPeter  LevyCOO; Executive VP CEDAR KNOLLSPeter  LevyPresident and COO CEDAR KNOLLSAronne  LouisMarina del ReyAronne  LouisCedar KnollsZHENGGUANG  LYUDirector CEDAR KNOLLSVICTOR E  MANDELDirector ARLINGTONJoseph  MannelloInterim CEO CEDAR KNOLLSJohn  NostaCEDAR KNOLLSCHRISTOPHER  PECHOCKDirector NEW YORKCHRISTOPHER  PECHOCKNEW YORKCHRISTOPHER  PECHOCKDirector CEDAR KNOLLSDiamandis  PeterMarina del ReyDiamandis  PeterCedar KnollsLevy  PeterMarina del ReyLevy  PeterCedar KnollsREN  RENDirector CEDAR KNOLLSRENS Agriculture Science & Technology Co, LtdNANJINGRENS Technology IncPOMONAHariri  RobertMarina del ReyHariri  RobertCedar KnollsSrivastava  SapnaCedar KnollsSapna  SrivastavaDirector CEDAR KNOLLSKenrick Bryce  ToussaintChief Executive Officer CEDAR KNOLLSJohn Craig  VenterDirector CEDAR KNOLLSGUIYING  ZHAOCEDAR KNOLLSBin  ZhouCEDAR KNOLLS












 






    Trend Analysis Report: MYOS RENS Technology Inc. (NASDAQ:MYOS) | Top Chronicle                LOG INWelcome! Log into your account   Forgot your password?Recover your password     TOP CHRONICLE BUSINESS NEWS AROUND THE WORLD  HomeWorldElectionsImmigrationMoreEconomy   Home  Business  Trend Analysis Report: MYOS RENS Technology Inc. (NASDAQ:MYOS)BusinessTrend Analysis Report: MYOS RENS Technology Inc. (NASDAQ:MYOS)By Koko Saunders - February 7, 201774   MYOS RENS Technology Inc. (NASDAQ:MYOS) traded with the volume of 3.6 Million in the previous trading session. The Stock opened its session at $3.42 and closed at $3.61 by showing decrease of -1.1 percent.There is no forecast data available. (CNN MONEY)MYOS RENS Technology Inc. (NASDAQ:MYOS) topped its 52-week high price of $6.98 on Jan 11, 2017 and 52-Week Low Price of $1.02 on Jan 4, 2017. The Stock currently has the market capitalization of $13.36 Million, P/E (price to earnings ttm) of 0 and Weekly volatility of 35.27% and monthly volatility of 44.50% respectively.MYOS RENS Technology Inc. Gross Margin percentage stands at -91% while its Operating Margin for trailing twelve month is 0 percent and Profit margin (ttm) is 0 Percent. The stock is currently moving above its 20-Day Simple Moving Average of 73.16% with the 50-Day Simple Moving Average of 73.16 percent. Currently, the company has SMA200 (200-day simple moving average) of 99.56 Percent. The Stock has YTD (year to date) performance of 205.93 percent.The latest Insider trade was made on 27 Dec 2016 where Lyu (Zhengguang) Director did a transaction type “Buy” in which 4386 shares were traded at a price of $0. Another insider trade includes Director Mandel (Victor E) who also initiated a transaction in which 1755 shares were traded on 27 Dec 2016 as “Buy”.Company Profile:MYOS RENS Technology Inc. is a BioNutrition and BioTherapeutics company which focused on the discovery, development and commercialization of products which improve muscle health and function essential to the management of sarcopenia, cachexia and degenerative muscle diseases. MYOS RENS Technology Inc., formerly known as MYOS Corporation, is based in Cedar Knolls, New Jersey.    RELATED ARTICLESMORE FROM AUTHOR BusinessFactors to Note Before Buying XPO Logistics, Inc. (XPO) BusinessRegulus Therapeutics Inc. (RGLS) Closed its Previous Trade at $1.1 BusinessCARBO Ceramics Inc. (CRR) hit its 1-Year High price on 02/10/17 BusinessBig 5 Sporting Goods Corp. (BGFV) hit his 1-Year Low price on 08/02/16 BusinessTripAdvisor Inc. (TRIP) closed its previous trading session at $37.27 BusinessIs MBIA Inc. (MBI) a good buy?RECENT POSTSFactors to Note Before Buying XPO Logistics, Inc. (XPO) Business Lauren Corfield -  July 25, 2017Regulus Therapeutics Inc. (RGLS) Closed its Previous Trade at $1.1 Business Koko Saunders -  July 25, 2017CARBO Ceramics Inc. (CRR) hit its 1-Year High price on 02/10/17 Business John Frost -  July 25, 2017Big 5 Sporting Goods Corp. (BGFV) hit his 1-Year Low price on 08/02/16 Business Jeremy -  July 25, 2017TripAdvisor Inc. (TRIP) closed its previous trading session at $37.27 Business James Ajayi -  July 25, 2017 TrendingAlibaba (NYSE:BABA) Founder Jack Ma Issues a Warning to the United... Business February 14, 2017AI Warning: Google’s Artificial Intelligence Turns Aggressive Business February 15, 2017YouTube Lunching Web-TV Service for $35 a Month, Takes on Cable Business March 3, 2017Ford (NYSE:F) is 3D Printing Large Car Parts to Offer More... Business March 6, 2017LinkedIn Won’t Comply With Russian Data Laws, To Be Blocked Business March 8, 2017TopChronicle is your news, business, finance and Global events website. We provide you with the latest news and videos straight from the economic sectors.                    Currently Trending  Factors to Note Before Buying Facebook, Inc. (FB)   Is Delcath Systems, Inc. (DCTH) a good buy?   Is Whiting Petroleum Corp. (WLL) a good buy?   Factors to Note Before Buying Valeant Pharmaceuticals International, Inc. (VRX)  Worth ReadingYamana Gold, Inc. (AUY) closed at $2.35 in the last trading... Business July 14, 2017Delcath Systems, Inc. (DCTH) has a Market value of 61.58 Million Business July 18, 2017Is AT&T, Inc. (T) a good buy? Business July 19, 2017Factors to Note Before Buying NVIDIA Corporation (NVDA) Business July 20, 2017Factors to Note Before Buying Facebook, Inc. (FB) Business July 24, 2017 Most Recent UpdatesFactors to Note Before Buying XPO Logistics, Inc. (XPO) Business July 25, 2017Regulus Therapeutics Inc. (RGLS) Closed its Previous Trade at $1.1 Business July 25, 2017CARBO Ceramics Inc. (CRR) hit its 1-Year High price on 02/10/17 Business July 25, 2017Big 5 Sporting Goods Corp. (BGFV) hit his 1-Year Low price... Business July 25, 2017TripAdvisor Inc. (TRIP) closed its previous trading session at $37.27 Business July 25, 2017HomeAboutPrivacyContact Us © Copyright TopChronicle      
    Business | Top Chronicle                LOG INWelcome! Log into your account   Forgot your password?Recover your password     TOP CHRONICLE BUSINESS NEWS AROUND THE WORLD  HomeWorldElectionsImmigrationMoreEconomy   Home  BusinessBusinessLatest LatestFeatured postsMost popular7 days popularBy review scoreRandom BusinessFactors to Note Before Buying XPO Logistics, Inc. (XPO) Lauren Corfield -  July 25, 2017 BusinessRegulus Therapeutics Inc. (RGLS) Closed its Previous Trade at $1.1 Koko Saunders -  July 25, 2017 BusinessCARBO Ceramics Inc. (CRR) hit its 1-Year High price on 02/10/17 John Frost -  July 25, 2017 BusinessBig 5 Sporting Goods Corp. (BGFV) hit his 1-Year Low price... Jeremy -  July 25, 2017 BusinessTripAdvisor Inc. (TRIP) closed its previous trading session at $37.27 James Ajayi -  July 25, 2017 BusinessIs MBIA Inc. (MBI) a good buy? Morgan Ford Jr -  July 25, 2017 BusinessDoes $59.93 justifies Brunswick Corporation (BC) shares? Koko Saunders -  July 25, 2017 BusinessHanesbrands Inc. (HBI) closed at $23.24 in the last trading session John Frost -  July 25, 2017 BusinessShopify Inc. (SHOP) has a Market value of 9.82 Billion Jeremy -  July 25, 2017 BusinessDoes IMAX Corporation (IMAX)’s current closing price competes the market? Colin Frost -  July 25, 2017123...3,986Page 1 of 3,986RECENT POSTSFactors to Note Before Buying XPO Logistics, Inc. (XPO) Business Lauren Corfield -  July 25, 2017Regulus Therapeutics Inc. (RGLS) Closed its Previous Trade at $1.1 Business Koko Saunders -  July 25, 2017CARBO Ceramics Inc. (CRR) hit its 1-Year High price on 02/10/17 Business John Frost -  July 25, 2017Big 5 Sporting Goods Corp. (BGFV) hit his 1-Year Low price on 08/02/16 Business Jeremy -  July 25, 2017TripAdvisor Inc. (TRIP) closed its previous trading session at $37.27 Business James Ajayi -  July 25, 2017 TrendingAlibaba (NYSE:BABA) Founder Jack Ma Issues a Warning to the United... Business February 14, 2017AI Warning: Google’s Artificial Intelligence Turns Aggressive Business February 15, 2017YouTube Lunching Web-TV Service for $35 a Month, Takes on Cable Business March 3, 2017Ford (NYSE:F) is 3D Printing Large Car Parts to Offer More... Business March 6, 2017LinkedIn Won’t Comply With Russian Data Laws, To Be Blocked Business March 8, 2017TopChronicle is your news, business, finance and Global events website. We provide you with the latest news and videos straight from the economic sectors.                    Currently Trending  Factors to Note Before Buying Facebook, Inc. (FB)   Is Delcath Systems, Inc. (DCTH) a good buy?   Is Whiting Petroleum Corp. (WLL) a good buy?   Factors to Note Before Buying Valeant Pharmaceuticals International, Inc. (VRX)  Worth ReadingYamana Gold, Inc. (AUY) closed at $2.35 in the last trading... Business July 14, 2017Delcath Systems, Inc. (DCTH) has a Market value of 61.58 Million Business July 18, 2017Is AT&T, Inc. (T) a good buy? Business July 19, 2017Factors to Note Before Buying NVIDIA Corporation (NVDA) Business July 20, 2017Factors to Note Before Buying Facebook, Inc. (FB) Business July 24, 2017 Most Recent UpdatesFactors to Note Before Buying XPO Logistics, Inc. (XPO) Business July 25, 2017Regulus Therapeutics Inc. (RGLS) Closed its Previous Trade at $1.1 Business July 25, 2017CARBO Ceramics Inc. (CRR) hit its 1-Year High price on 02/10/17 Business July 25, 2017Big 5 Sporting Goods Corp. (BGFV) hit his 1-Year Low price... Business July 25, 2017TripAdvisor Inc. (TRIP) closed its previous trading session at $37.27 Business July 25, 2017HomeAboutPrivacyContact Us © Copyright TopChronicle      


MYOS MYOS RENS Technology Inc. Stock Quote
















Your browser is no longer supported. Please, upgrade your browser.





































HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexBacktestsElite




                        Help
                    

Login
Register











TIP: 
Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.
                        ×








publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
















MYOS [NASD]
MYOS RENS Technology Inc.
Healthcare | Drugs - Generic | USA









financial highlights | statements









Index-
P/E-
EPS (ttm)-0.81
Insider Own-
Shs Outstand5.86M
Perf Week-9.57%


Market Cap9.96M
Forward P/E-
EPS next Y-
Insider Trans-
Shs Float3.24M
Perf Month-4.49%


Income-4.20M
PEG-
EPS next Q-
Inst Own3.00%
Short Float13.11%
Perf Quarter-29.17%


Sales0.30M
P/S33.21
EPS this Y44.80%
Inst Trans-
Short Ratio6.26
Perf Half Y-40.35%


Book/sh1.10
P/B1.55
EPS next Y-
ROA-63.20%
Target Price-
Perf Year-14.14%


Cash/sh0.38
P/C4.53
EPS next 5Y-
ROE-73.80%
52W Range1.02 - 6.98
Perf YTD44.07%


Dividend-
P/FCF-
EPS past 5Y27.60%
ROI-81.30%
52W High-75.36%
Beta0.31


Dividend %-
Quick Ratio5.50
Sales past 5Y26.90%
Gross Margin14.50%
52W Low68.63%
ATR0.13


Employees9
Current Ratio9.50
Sales Q/Q0.00%
Oper. Margin-
RSI (14)37.95
Volatility4.34% 7.91%


OptionableNo
Debt/Eq0.00
EPS Q/Q35.00%
Profit Margin-
Rel Volume0.13
Prev Close1.70


ShortableYes
LT Debt/Eq0.00
EarningsAug 11
Payout-
Avg Volume67.82K
Price1.72


Recom2.00
SMA20-8.80%
SMA50-14.57%
SMA200-23.28%
Volume7,618
Change1.18%















Jul-12-17 06:12AM  MYOS RENS to Introduce the Qurr® Line of Muscle Health Products at 35th IDEA World Convention July 19-23, 2017 in Las Vegas PR Newswire
Jun-02-17 09:54AM  MYOS RENS Technology, Inc. :MYOS-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017 Capital Cube
Apr-24-17 06:05AM  MYOS RENS Will Be Silver Sponsor at International Conference on Frailty and Sarcopenia Research (ICFSR) PR Newswire +6.67%
Apr-18-17 06:05AM  MYOS RENS enters into agreement with Kansas State University to study impact of Fortetropin® on reducing muscle loss in dogs after joint surgery PR Newswire +5.80%
Apr-06-17 12:05PM  MYOS RENS Technology, Inc. :MYOS-US: Earnings Analysis: Q4, 2016 By the Numbers : April 6, 2017 Capital Cube
09:54AM  MYOS RENS Technology, Inc. :MYOS-US: Earnings Analysis: 2016 By the Numbers : April 6, 2017 Capital Cube
Mar-31-17 06:11AM  MYOS RENS TECHNOLOGY INC. Files SEC form 10-K, Annual Report 
06:01AM  MYOS RENS Technology to host April 4 interactive conference call on "Qurr" product launch PR Newswire
Mar-13-17 06:00AM  Are you Qurr-ious? MYOS Rens Technology Inc. Launches Qurr Product Line Powered by Fortetropin®, an All-Natural Ingredient Clinically Proven to Increase Muscle Size and Mass PR Newswire
Mar-01-17 03:26PM  'Qurr' line of revolutionary muscle-health and muscle-building products in newly-enhanced form set for March rollout Marketwired +11.55%
Feb-21-17 08:36AM  MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Ex  -17.85%
Feb-14-17 06:13PM  MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to Ri 
06:00PM  MYOS RENS Technology Inc. Adopts Shareholder Rights Plan Marketwired
Feb-07-17 05:05PM  MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, F  +30.75%
Feb-06-17 09:30AM  Key Catalyst That Could Send Biotechs Soaring in 2017: Today's Reports on MYOS RENS Technology and Actinium Pharmaceuticals Accesswire
Feb-03-17 02:54PM  MYOS RENS Technology Inc. Announces $2,125,000 Registered Direct Offering Marketwired +37.22%
Jan-30-17 08:00AM  Dr. Robert Hariri, stem cell pioneer and chairman of MYOS RENS Technology, states that 'healthy muscle is key to overall health and wellness' Marketwired
Jan-23-17 04:43PM  MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Change in Directors or Principal Officers  -7.47%
Jan-11-17 04:46PM  MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other  +424.62%
Dec-22-16 04:31PM  MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders 
Nov-25-16 08:01AM  MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Entry into a Material Definitive Agreement  +6.00%
Nov-22-16 01:04PM  MYOS RENS TECHNOLOGY INC. Financials 
Nov-18-16 11:46AM  MYOS RENS Technology, Inc. :MYOS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 18, 2016 Capital Cube
Nov-14-16 04:13PM  MYOS RENS TECHNOLOGY INC. Files SEC form 10-Q, Quarterly Report  +6.90%
Sep-29-16 08:00AM  MYOS RENS Announces Publication of Its Fortetropin(R) Human Clinical Trial Manuscript Marketwired -6.86%
Sep-07-16 12:32PM  MYOS RENS Technology Inc. Appoints Joseph Mannello as Interim Chief Executive Officer Marketwired
Aug-31-16 08:01AM  MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Change in Directors or Principal Officers 
Aug-24-16 04:17PM  MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events 
Aug-12-16 08:34AM  MYOS RENS TECHNOLOGY INC. Files SEC form 10-Q, Quarterly Report 
Aug-08-16 04:35PM  MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Change in Directors or Principal Officers 
Jun-29-16 04:17PM  MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Change in Directors or Principal Officers  +11.60%
Jun-22-16 11:58AM  MYOS RENS Technology, Inc. :MYOS-US: Earnings Analysis: Q1, 2016 By the Numbers : June 22, 2016 Capital Cube -9.09%
May-20-16 05:26PM  MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant 
May-13-16 08:34AM  MYOS RENS TECHNOLOGY INC. Files SEC form 10-Q, Quarterly Report 
Apr-22-16 03:00PM  MYOS Reports Positive Results From Fortetropin(R) Clinical Study Marketwired
Apr-11-16 08:51AM  MYOS RENS Technology, Inc. :MYOS-US: Earnings Analysis: Q4, 2015 By the Numbers 
07:49AM  MYOS RENS Technology, Inc. :MYOS-US: Earnings Analysis: 2015 By the Numbers 
Mar-30-16 05:53PM  MYOS RENS TECHNOLOGY INC. Files SEC form 10-K, Annual Report 
Mar-23-16 05:21AM  MYOS Corporation Announces Corporate Name Change to MYOS RENS Technology Inc. at noodls -8.02%
Mar-22-16 04:33PM  MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financ  +11.31%
07:33AM  MYOS Corporation Announces Corporate Name Change to MYOS RENS Technology Inc. Marketwired
Mar-08-16 05:31PM  MYOS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Cha 
04:17PM  MYOS Corporation Announces Election of New Directors and Appointment of Ren Ren as Global Chairman Marketwired
Mar-04-16 08:30AM  MYOS Corporation Announces the Initial Closing of a Strategic Investment by RENS Technology Inc. Marketwired
Feb-04-16 05:21PM  MYOS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Other Events 
Dec-22-15 05:09PM  MYOS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation o 
Dec-21-15 04:32PM  MYOS CORP Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters 
Dec-17-15 01:55PM  Why Are These Stocks Gaining Ground on Thursday? at Insider Monkey +56.84%
11:00AM  4 Stocks Under $10 That Need To Be Watched Today Accesswire
08:00AM  MYOS Corporation Announces Strategic Investment by RENS Technology Inc. Marketwired
Nov-30-15 05:21PM  MYOS CORP Files SEC form 8-K, Other Events 
Nov-16-15 05:15PM  MYOS CORP Files SEC form 10-Q, Quarterly Report  +56.98%
Nov-03-15 12:08PM  MYOS Corp.  Value Analysis (NASDAQ:MYOS) : November 3, 2015  -5.53%
Oct-26-15 07:35AM  Maintaining Muscle Linked to Preserving Healthy Brain Tissue Marketwired
Oct-19-15 07:35AM  MYOS' Proprietary Muscle Building Technology Fortetropin: Foundation for New Dietary Recommendations Marketwired +6.55%
Oct-02-15 10:53AM  MYOS Corp. Earnings Q2, 2015  +9.27%
Oct-01-15 08:00AM  Cryoport Appoints Robert Hariri, MD, PhD to its Board of Directors PR Newswire +16.79%
Aug-20-15 04:17PM  MYOS CORP Files SEC form 8-K, Change in Directors or Principal Officers  -11.73%
Aug-16-15 08:12PM  10-Q for MYOS Corp. at Company Spotlight
Aug-14-15 06:14PM  MYOS CORP Files SEC form 10-Q, Quarterly Report 
04:45PM  MYOS Corporation to Host Conference Call to Discuss Management Highlights Marketwired
Jul-22-15 07:35AM  MYOS Corporation Launches Optimized Re Muscle Health(TM) Website and HealthTrac App Marketwired
Jun-24-15 07:35AM  MYOS Corporation Issues Letter to Shareholders Highlighting Key Accomplishments Marketwired
Jun-11-15 07:35AM  MYOS Corporation Publishes Research Article on the Impact of Fertility on the Chicken Egg Yolk Proteome in Peer-Reviewed Journal Marketwired
May-28-15 07:35AM  MYOS Corporation Receives Health Canada Approval of Proprietary Ingredient Fortetropin(R) Marketwired
May-26-15 07:35AM  MYOS Corporation Initiates Marketing Plan for Re Muscle Health(TM) Products Marketwired
May-19-15 08:22AM  MYOS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to Rights of Security 
07:35AM  Astronaut Buzz Aldrin Relies on Re Muscle Health(TM) Products to Help Rebuild, Rejuvenate and Maintain Lean Muscle Marketwired
May-17-15 08:11PM  10-Q for MYOS Corp. at Company Spotlight
May-14-15 08:02AM  MYOS CORP Files SEC form 10-Q, Quarterly Report 
07:07AM  Q1 2015 MYOS Corp Earnings Release - Before Market Open 
May-12-15 07:35AM  MYOS Corporation to Host Conference Call to Discuss Quarterly Update and Management Highlights Marketwired
May-11-15 07:35AM  MYOS Corporation Initiates Clinical Study on Fortetropin(R) Dose Response Marketwired
Apr-29-15 08:15PM  10-K for MYOS Corp. at Company Spotlight
Mar-30-15 07:59AM  MYOS Corporation Announces the Re Muscle Health(TM) Series Powered by Fortetropin(R) at noodls
07:35AM  MYOS Corporation Announces the Re Muscle Health(TM) Series Powered by Fortetropin(R) Marketwired
Mar-27-15 04:59PM  MYOS CORP Files SEC form 10-K, Annual Report 
04:57PM  MYOS Corporation to Host Conference Call to Discuss Quarterly Update and Management Highlights at noodls
04:35PM  MYOS Corporation to Host Conference Call to Discuss Quarterly Update and Management Highlights Marketwired
Mar-06-15 08:36AM  iHeart Radio's "HealthTech Talk" Show to Feature MYOS Corporation's Ingredient Fortetropin(TM) in Exclusive Interview With Company Chairman at noodls
07:15AM  iHeart Radio's "HealthTech Talk" Show to Feature MYOS Corporation's Ingredient Fortetropin(TM) in Exclusive Interview With Company Chairman Marketwired
Feb-23-15 08:27AM  MYOS Corporation to Present Mechanism of Action Data at the Experimental Biology Conference at noodls
07:30AM  MYOS Corporation to Present Mechanism of Action Data at the Experimental Biology Conference Marketwired
Feb-12-15 07:15AM  Chairman Dr. Robert Hariri of MYOS Corporation to Be Interviewed Live on Clear Channel's "The Trader's Network Show" Marketwired
Feb-11-15 08:05AM  MYOS Corporation Research Selected to Be Presented at International Conference on Molecular and Cellular Biology Marketwired
Jan-22-15 08:53AM  MYOS Corporation's Preclinical Study of Fortetropin's(TM) Mechanism of Action Demonstrate Regulatory Effects on Three Key Muscle Health Pathways at noodls
08:00AM  MYOS Corporation's Preclinical Study of Fortetropin's(TM) Mechanism of Action Demonstrate Regulatory Effects on Three Key Muscle Health Pathways Marketwired
Jan-07-15 07:05AM  MYOS Corporation to Present at the Eighth Annual OneMedForum Conference on January 13, 2015 Marketwired
Dec-23-14 04:35PM  MYOS CORP Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters EDGAR Online
Dec-01-14 04:11PM  MYOS CORP Files SEC form 8-K, Other Events EDGAR Online
Nov-19-14 05:27PM  MYOS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Stateme EDGAR Online
Nov-18-14 09:25AM  MYOS Corporation Announces $1.81 Million Registered Direct Offering Marketwired
Nov-15-14 07:07PM  10-Q for MYOS Corp. Company Spotlight
Nov-14-14 04:27PM  MYOS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Stat EDGAR Online
10:30AM  MYOS Corporation Reports 2014 Third Quarter Results and Provides Business Update Marketwired
Nov-13-14 05:20PM  MYOS CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
Nov-11-14 07:05AM  MYOS Corporation to Announce Third Quarter 2014 Financial Results and Host Conference Call on November 14, 2014 Marketwired
Nov-04-14 08:05AM  MYOS Corporation Announces Positive Safety Data Demonstrating Fortetropin's(TM) Lack of Adverse Effect on Serum Lipids and Cholesterol Levels Marketwired
Oct-30-14 07:35AM  MYOS Corporation Announces Statistically Significant Top-Line Clinical Data Demonstrating Fortetropin's(TM) Anti-Inflammatory BioTherapeutic Properties Marketwired
Oct-02-14 08:05AM  MYOS Corporation to Present Positive Clinical Data at 55th Annual Conference of the American College of Nutrition Marketwired







MYOS RENS Technology Inc., a bionutrition and biotherapeutics company, focuses on the discovery, development, and commercialization of nutritional and therapeutic products for maintaining and enhancing the health and performance of muscle tissue. The company primarily focuses on developing the products that enhance muscle health and function essential to the management of sarcopenia, cachexia, and degenerative muscle diseases, and as an adjunct to the treatment of obesity. Its products include Re Muscle Health products, a direct-to-consumer portfolio of muscle health bars, meal replacement shakes, and daily supplement powders; and Qurr line of products comprising flavored puddings, powders, and shakes. The company sells its Re Muscle Health products through e-commerce Websites; and Qurr line of products through convenient direct online ordering without a prescription. The company was formerly known as MYOS Corporation and changed its name to MYOS RENS Technology Inc. in March 2016. MYOS RENS Technology Inc. was founded in 2007 and is based in Cedar Knolls, New Jersey.





Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4

LYU ZHENGGUANGDirectorDec 02Buy1.539311,424117,842Dec 09 01:39 PMLYU ZHENGGUANGDirectorDec 01Buy1.4714,92321,998116,911Dec 09 01:39 PMLYU ZHENGGUANGDirectorNov 30Buy1.4318,48326,431101,988Dec 09 01:39 PM







open in yahoo | open in reuters | open in google






















×


Upgrade your FINVIZ experience

                                        Join thousands of traders who make more informed decisions with our premium features.
                                        Real-time quotes, advanced visualizations, backtesting, and much more.
                                    
Learn more about FINVIZ*Elite






	EDGAR ONLINE - MYOS RENS TECHNOLOGY INC. - SEC FILINGS































                                     
                                




Welcome


                                                |
                                            

Help


                                                |
                                            

About EDGAR Online
                                                   


                                                |
                                            

 Login 















Dashboard 

Today 
Company

Industry

Search
Screener

Analytics




































MYOS RENS TECHNOLOGY INC.: MYOS  (Nasdaq Capital Market)











Enter your Email to Learn More:  
                                 












Form






                         (Filer)
                    

                         Received

                        (
                        Period
                        
                        ) 
                    


10-Q

MYOS RENS TECHNOLOGY INC.
 05/12/17 (03/31/17) 


CT ORDER

MYOS RENS TECHNOLOGY INC.
 04/10/17 


10-K

MYOS RENS TECHNOLOGY INC.
 03/31/17 (12/31/16) 


8-K

MYOS RENS TECHNOLOGY INC.
 02/21/17 (02/21/17) 


424B5

MYOS RENS TECHNOLOGY INC.
 02/21/17 


8-A12B

MYOS RENS TECHNOLOGY INC.
 02/14/17 


8-K

MYOS RENS TECHNOLOGY INC.
 02/14/17 (02/14/17) 


8-K

MYOS RENS TECHNOLOGY INC.
 02/07/17 (02/03/17) 


424B5

MYOS RENS TECHNOLOGY INC.
 02/07/17 


8-K

MYOS RENS TECHNOLOGY INC.
 01/23/17 (01/17/17) 


8-K

MYOS RENS TECHNOLOGY INC.
 01/11/17 (01/06/17) 


4

MYOS RENS TECHNOLOGY INC.(MANDEL VICTOR E) 
 12/30/16 (12/28/16) 


4

MYOS RENS TECHNOLOGY INC.(HARIRI ROBERT J) 
 12/30/16 (12/28/16) 


4

MYOS RENS TECHNOLOGY INC.(LYU ZHENGGUANG) 
 12/30/16 (12/28/16) 


4

MYOS RENS TECHNOLOGY INC.(MANNELLO JOSEPH) 
 12/30/16 (11/15/16) 


4

MYOS RENS TECHNOLOGY INC.(PECHOCK CHRISTOPHER) 
 12/30/16 (12/28/16) 


3

MYOS RENS TECHNOLOGY INC.(NOSTA JOHN) 
 12/30/16 (12/21/16) 


8-K

MYOS RENS TECHNOLOGY INC.
 12/22/16 (12/21/16) 


4

MYOS RENS TECHNOLOGY INC.(LYU ZHENGGUANG) 
 12/09/16 (11/30/16) 


8-K

MYOS RENS TECHNOLOGY INC.
 11/25/16 (11/18/16) 




                             
                        












             Results 1 - 20 of 280




 


  
            
                    [1]
2
3
4
5
6
7
8
9
10
                
             
            Next 4 Pages


[ Show Next 20 Results ] 
























Last Trade













Last Trade: 
$1.72
                 
            
Change: 

0.02 (1.18%)
                 
            
Trade Time: 
01:33 PM EST
                 
            
Market Cap: 
$10.05M







Trade MYOS now with 























© 2017
                                
 
                                
























                 
            











            © 1995-2017

EDGAR® Online, a division of Donnelley Financial Solutions.
            All rights reserved  Solutions
                for Corporations 
            Terms of Use
             
                Privacy Statement










    Traders Review: MYOS RENS Technology Inc. (NASDAQ:MYOS) | Top Chronicle                LOG INWelcome! Log into your account   Forgot your password?Recover your password     TOP CHRONICLE BUSINESS NEWS AROUND THE WORLD  HomeWorldElectionsImmigrationMoreEconomy   Home  Business  Traders Review: MYOS RENS Technology Inc. (NASDAQ:MYOS)BusinessTraders Review: MYOS RENS Technology Inc. (NASDAQ:MYOS)By Colin Frost - January 13, 201715   There is no forecast data available. (CNN MONEY)MYOS RENS Technology Inc. (NASDAQ:MYOS) topped its 52-week high price of $6.98 on Jan 11, 2017 and 52-Week Low Price of $1.02 on Jan 4, 2017. The Stock currently has the market capitalization of $18.6 Million, P/E (price to earnings ttm) of 0 and Weekly volatility of 109.76% and monthly volatility of 34.18% respectively.MYOS RENS Technology Inc. Gross Margin percentage stands at -91% while its Operating Margin for trailing twelve month is 0 percent and Profit margin (ttm) is 0 Percent. The stock is currently moving above its 20-Day Simple Moving Average of 142.29% with the 50-Day Simple Moving Average of 142.29 percent. Currently, the company has SMA200 (200-day simple moving average) of 118.17 Percent. The Stock has YTD (year to date) performance of 217.8 percent.The latest Insider trade was made on 27 Dec 2016 where Lyu (Zhengguang) Director did a transaction type “Buy” in which 4386 shares were traded at a price of $0. Another insider trade includes Director Hariri (Robert J) who also initiated a transaction in which 4386 shares were traded on 27 Dec 2016 as “Buy”.Company Profile:MYOS RENS Technology Inc. is a BioNutrition and BioTherapeutics company which focused on the discovery, development and commercialization of products which improve muscle health and function essential to the management of sarcopenia, cachexia and degenerative muscle diseases. MYOS RENS Technology Inc., formerly known as MYOS Corporation, is based in Cedar Knolls, New Jersey.    RELATED ARTICLESMORE FROM AUTHOR BusinessFactors to Note Before Buying XPO Logistics, Inc. (XPO) BusinessRegulus Therapeutics Inc. (RGLS) Closed its Previous Trade at $1.1 BusinessCARBO Ceramics Inc. (CRR) hit its 1-Year High price on 02/10/17 BusinessBig 5 Sporting Goods Corp. (BGFV) hit his 1-Year Low price on 08/02/16 BusinessTripAdvisor Inc. (TRIP) closed its previous trading session at $37.27 BusinessIs MBIA Inc. (MBI) a good buy?RECENT POSTSFactors to Note Before Buying XPO Logistics, Inc. (XPO) Business Lauren Corfield -  July 25, 2017Regulus Therapeutics Inc. (RGLS) Closed its Previous Trade at $1.1 Business Koko Saunders -  July 25, 2017CARBO Ceramics Inc. (CRR) hit its 1-Year High price on 02/10/17 Business John Frost -  July 25, 2017Big 5 Sporting Goods Corp. (BGFV) hit his 1-Year Low price on 08/02/16 Business Jeremy -  July 25, 2017TripAdvisor Inc. (TRIP) closed its previous trading session at $37.27 Business James Ajayi -  July 25, 2017 TrendingAlibaba (NYSE:BABA) Founder Jack Ma Issues a Warning to the United... Business February 14, 2017AI Warning: Google’s Artificial Intelligence Turns Aggressive Business February 15, 2017YouTube Lunching Web-TV Service for $35 a Month, Takes on Cable Business March 3, 2017Ford (NYSE:F) is 3D Printing Large Car Parts to Offer More... Business March 6, 2017LinkedIn Won’t Comply With Russian Data Laws, To Be Blocked Business March 8, 2017TopChronicle is your news, business, finance and Global events website. We provide you with the latest news and videos straight from the economic sectors.                    Currently Trending  Factors to Note Before Buying Facebook, Inc. (FB)   Is Delcath Systems, Inc. (DCTH) a good buy?   Is Whiting Petroleum Corp. (WLL) a good buy?   Factors to Note Before Buying Valeant Pharmaceuticals International, Inc. (VRX)  Worth ReadingYamana Gold, Inc. (AUY) closed at $2.35 in the last trading... Business July 14, 2017Delcath Systems, Inc. (DCTH) has a Market value of 61.58 Million Business July 18, 2017Is AT&T, Inc. (T) a good buy? Business July 19, 2017Factors to Note Before Buying NVIDIA Corporation (NVDA) Business July 20, 2017Factors to Note Before Buying Facebook, Inc. (FB) Business July 24, 2017 Most Recent UpdatesFactors to Note Before Buying XPO Logistics, Inc. (XPO) Business July 25, 2017Regulus Therapeutics Inc. (RGLS) Closed its Previous Trade at $1.1 Business July 25, 2017CARBO Ceramics Inc. (CRR) hit its 1-Year High price on 02/10/17 Business July 25, 2017Big 5 Sporting Goods Corp. (BGFV) hit his 1-Year Low price... Business July 25, 2017TripAdvisor Inc. (TRIP) closed its previous trading session at $37.27 Business July 25, 2017HomeAboutPrivacyContact Us © Copyright TopChronicle      
    Business | Top Chronicle                LOG INWelcome! Log into your account   Forgot your password?Recover your password     TOP CHRONICLE BUSINESS NEWS AROUND THE WORLD  HomeWorldElectionsImmigrationMoreEconomy   Home  BusinessBusinessLatest LatestFeatured postsMost popular7 days popularBy review scoreRandom BusinessFactors to Note Before Buying XPO Logistics, Inc. (XPO) Lauren Corfield -  July 25, 2017 BusinessRegulus Therapeutics Inc. (RGLS) Closed its Previous Trade at $1.1 Koko Saunders -  July 25, 2017 BusinessCARBO Ceramics Inc. (CRR) hit its 1-Year High price on 02/10/17 John Frost -  July 25, 2017 BusinessBig 5 Sporting Goods Corp. (BGFV) hit his 1-Year Low price... Jeremy -  July 25, 2017 BusinessTripAdvisor Inc. (TRIP) closed its previous trading session at $37.27 James Ajayi -  July 25, 2017 BusinessIs MBIA Inc. (MBI) a good buy? Morgan Ford Jr -  July 25, 2017 BusinessDoes $59.93 justifies Brunswick Corporation (BC) shares? Koko Saunders -  July 25, 2017 BusinessHanesbrands Inc. (HBI) closed at $23.24 in the last trading session John Frost -  July 25, 2017 BusinessShopify Inc. (SHOP) has a Market value of 9.82 Billion Jeremy -  July 25, 2017 BusinessDoes IMAX Corporation (IMAX)’s current closing price competes the market? Colin Frost -  July 25, 2017123...3,986Page 1 of 3,986RECENT POSTSFactors to Note Before Buying XPO Logistics, Inc. (XPO) Business Lauren Corfield -  July 25, 2017Regulus Therapeutics Inc. (RGLS) Closed its Previous Trade at $1.1 Business Koko Saunders -  July 25, 2017CARBO Ceramics Inc. (CRR) hit its 1-Year High price on 02/10/17 Business John Frost -  July 25, 2017Big 5 Sporting Goods Corp. (BGFV) hit his 1-Year Low price on 08/02/16 Business Jeremy -  July 25, 2017TripAdvisor Inc. (TRIP) closed its previous trading session at $37.27 Business James Ajayi -  July 25, 2017 TrendingAlibaba (NYSE:BABA) Founder Jack Ma Issues a Warning to the United... Business February 14, 2017AI Warning: Google’s Artificial Intelligence Turns Aggressive Business February 15, 2017YouTube Lunching Web-TV Service for $35 a Month, Takes on Cable Business March 3, 2017Ford (NYSE:F) is 3D Printing Large Car Parts to Offer More... Business March 6, 2017LinkedIn Won’t Comply With Russian Data Laws, To Be Blocked Business March 8, 2017TopChronicle is your news, business, finance and Global events website. We provide you with the latest news and videos straight from the economic sectors.                    Currently Trending  Factors to Note Before Buying Facebook, Inc. (FB)   Is Delcath Systems, Inc. (DCTH) a good buy?   Is Whiting Petroleum Corp. (WLL) a good buy?   Factors to Note Before Buying Valeant Pharmaceuticals International, Inc. (VRX)  Worth ReadingYamana Gold, Inc. (AUY) closed at $2.35 in the last trading... Business July 14, 2017Delcath Systems, Inc. (DCTH) has a Market value of 61.58 Million Business July 18, 2017Is AT&T, Inc. (T) a good buy? Business July 19, 2017Factors to Note Before Buying NVIDIA Corporation (NVDA) Business July 20, 2017Factors to Note Before Buying Facebook, Inc. (FB) Business July 24, 2017 Most Recent UpdatesFactors to Note Before Buying XPO Logistics, Inc. (XPO) Business July 25, 2017Regulus Therapeutics Inc. (RGLS) Closed its Previous Trade at $1.1 Business July 25, 2017CARBO Ceramics Inc. (CRR) hit its 1-Year High price on 02/10/17 Business July 25, 2017Big 5 Sporting Goods Corp. (BGFV) hit his 1-Year Low price... Business July 25, 2017TripAdvisor Inc. (TRIP) closed its previous trading session at $37.27 Business July 25, 2017HomeAboutPrivacyContact Us © Copyright TopChronicle      



 Ownership Submission 





FORM 4


Check this box if no longer subject to Section 16.  Form 4 or Form 5 obligations may continue.  See Instruction 1(b).




	UNITED STATES SECURITIES AND EXCHANGE COMMISSION
	Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
	


OMB APPROVAL

OMB Number:
3235-0287


Estimated average burden hours per response...
0.5




(Print or Type Responses)



1. Name and Address of Reporting Person *
LYU ZHENGGUANG

 
	      2. Issuer Name and Ticker or Trading SymbolMYOS RENS TECHNOLOGY INC. [MYOS]
	      

5. Relationship of Reporting Person(s) to Issuer(Check all applicable)

__X__ Director
_____ 10% Owner


_____ Officer (give title below)
_____ Other (specify below)








(Last)
(First)
(Middle)
16TH FLOOR, BUILDING A, FENGHUO PLAZA, NO.88 YUN LONG SHAN ROAD

3. Date of Earliest Transaction (Month/Day/Year)11/30/2016




(Street)

NANJING, F4 210019

4. If Amendment, Date Original Filed(Month/Day/Year)


6. Individual or Joint/Group Filing(Check Applicable Line)
		  _X_ Form filed by One Reporting Person
		  ___ Form filed by More than One Reporting Person
		




(City)
(State)
(Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned




1.Title of Security(Instr. 3)
2. Transaction Date (Month/Day/Year)
2A. Deemed Execution Date, if any (Month/Day/Year)
3. Transaction Code(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)(Instr. 4)
7. Nature of Indirect Beneficial Ownership(Instr. 4)


Code
V
Amount
(A) or (D)
Price



                Common Stock
            
11/30/2016

		   
		
P

	           
        	 

                    18,483
                

                    A
                

	          $
                    1.43
                

                    101,988
                

                    D
                

		   
		



                Common Stock
            
12/01/2016

		   
		
P

	           
        	 

                    11,323
                

                    A
                

	          $
                    1.45
                

                    113,311
                

                    D
                

		   
		



                Common Stock
            
12/01/2016

		   
		
P

	           
        	 

                    3,600
                

                    A
                

	          $
                    1.55
                

                    116,911
                

                    D
                

		   
		



                Common Stock
            
12/02/2016

		   
		
P

	           
        	 

                    931
                

                    A
                

	          $
                    1.53
                

                    117,842
                

                    D
                

		   
		






Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.




Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
SEC 1474 (9-02)



Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security(Instr. 3)
2. Conversion or Exercise Price of Derivative Security
3. Transaction Date (Month/Day/Year)
3A. Deemed Execution Date, if any (Month/Day/Year)
4. Transaction Code(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date(Month/Day/Year)
7. Title and Amount of Underlying Securities(Instr. 3 and 4)
8. Price of Derivative Security(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)(Instr. 4)
11. Nature of Indirect Beneficial Ownership(Instr. 4)


Code
V
(A)
(D)
Date Exercisable
Expiration Date
Title
Amount or Number of Shares



Reporting Owners


Reporting Owner Name / Address
Relationships


 Director

 10% Owner

 Officer

 Other



LYU ZHENGGUANG16TH FLOOR, BUILDING A, FENGHUO PLAZANO.88 YUN LONG SHAN ROADNANJING, F4 210019
 
	
            X
          
 
	
 
	

	     
	  


Signatures



 /s/Zhengguang Lyu

 
	12/09/2016


**Signature of Reporting Person

Date



Explanation of Responses:



*
If the form is filed by more than one reporting person, see Instruction 4(b)(v).


**
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.  See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).




Note: File three copies of this Form, one of which must be manually signed.  If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.


